Stryker Corporation

Cactus, LLC

David A Maness

Brian James VanDerWoude

Lucas Wade

Bryan Matthew Ulmer

Heather Benoit

Stephen Reiger Myers

Dennis B Meyer

Logan Castillo

Brian VanderWoude

Brian J Vanderwoude

A waste disposal system for receiving pharmaceutical waste material including at least one of a solid phase pharmaceutical waste material and a liquid phase pharmaceutical waste material is provided. The waste receiver includes a receiver body defining an opening. The waster receiver further includes an inner surface defining a container volume in fluid communication with the opening, and an outer surface opposite the inner surface. The outer surface defines a lock passageway separate from the opening. The system further includes a bracket adapted to be secured to a fixed surface and a locking assembly coupled to the bracket and adapted to releasably secure the waste receiver to the fixed surface. The locking assembly includes a lock housing sized to be removably positioned at least partially within the lock passageway.

Waste disposal system and waste receiver for receiving and disposing of pharmaceutical waste material

A method of disposing of a residual pharmaceutical composition from an IV bag includes coupling the IV bag to a pharmaceutical dispenser coupler. The method also includes extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler. The method further includes treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner.

Pharmaceutical waste system

A waste disposal system with a waste receiver for receiving pharmaceutical waste material. A locking assembly is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall of a receiver body of the waste receiver to engage a locking feature of the cover in the locked configuration. A cover retention feature may prevent axial decoupling of the cover from the receiver body. The receiver body may be formed from two shells. A reaction agent is positioned within the container volume and spaced apart from a bottom wall of the receiver body. The reaction agent may be positioned within the container volume between the lock passageway and/or a solid receiver volume, and opposing sidewalls of the receiver body. A support may maintain the position of the reaction agent within the container volume.

Waste receiver for receiving a pharmaceutical waste material

An assembly for receiving fluid pharmaceutical waste into a fluid waste receiver includes a fluid receiver body coupled to a fluid receiver cap, and receiving solid pharmaceutical waste into a solid waste receiver includes a solid receiver body coupled to a solid receiver cap. The assembly comprises a receiver housing and a receiver lid coupled to the receiver housing. The receiver housing comprises a retainer base, sidewalls extending from the retainer base, and dividers extending from the sidewalls to divide an interior of the receiver housing into a receiver compartment configured to receive the fluid receiver body and the solid receiver body, and a cap compartment. A first of the dividers divides the receiver compartment from a first of the cap compartments configured to receive the fluid receiver cap, and a second one of the dividers divides the receiver compartment from a second of the cap compartments configured to receive the solid receiver cap.

Pharmaceutical waste disposal assembly

A waste disposal system () with a waste receiver () for receiving pharmaceutical waste material. A locking assembly () is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall () of a receiver body () of the waste receiver to engage a locking feature of a cover () in the locked configuration. A cover retention feature () may prevent axial decoupling of the cover from the receiver body. The receiver body may be formed from two shells (). A reaction agent () is positioned within the container volume and spaced apart from a bottom wall of the receiver body. The reaction agent may be positioned within the container volume between the lock passageway () and/or a solid receiver volume, and opposing sidewalls of the receiver body. A support may maintain the position of the reaction agent within the container volume.

Method of disposing of waste receiver, waste receiver for pharmaceutical waste and method of assembling the waste receiver

A waste receiver for receiving pharmaceutical waste material and adapted to be releasably secured to a fixed surface is disclosed. The waste receiver comprises a receiver body with a fluid absorber and a chemical composition disposed within the receiver body. The receiver body defines an opening for receiving the pharmaceutical waste material and comprises an inner surface defining a container volume in fluid communication with the opening, and an outer surface opposite the inner surface with the outer surface defining a lock passageway through the receiver body and a keyway comprising a portion of the lock passageway. The lock passageway is adapted to receive a locking assembly and the keyway is adapted to receive an engagement feature of the locking assembly to releasably secure the waste receiver to the locking assembly in a single orientation. The waste receiver also comprises a cover adapted to be coupled with the receiver body.

A waste disposal system with a waste receiver for receiving pharmaceutical waste material. A locking assembly is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall of a receiver body of the waste receiver to engage a locking feature of the cover in the locked configuration. A cover retention feature may prevent axial decoupling of the cover from the receiver body. An engagement feature is moved to be disengaged from the receiver body, and the receiver body is moved away from the fixed surface to disengage the locking assembly from the cover. The cover is decoupled from the cover retention feature, and coupled with the receiver body to seal the pharmaceutical waste material. The locking assembly may be removed from a lock passageway for disposal of the waste receiver.

A pharmaceutical waste disposal assembly includes a fluid receiver body for receiving fluid pharmaceutical waste, said fluid receiver body may comprise a material that is clear, opaque, or otherwise see-through and having a capacity. The assembly also includes a first reaction agent positioned within the fluid receiver body, the fluid pharmaceutical waste contacting the first reaction agent to change the fluid pharmaceutical waste in one of a chemical and physical manner so that the fluid pharmaceutical waste is rendered unrecoverable. The assembly also includes a fluid absorber positioned within said fluid receiver body, said fluid absorber configured to absorb and retain fluid pharmaceutical waste deposited in said fluid receiver body. The assembly also includes a moisture-sensitive visual indicator that changes color when fluid pharmaceutical waste deposited in said fluid receiver body has reached a predetermined percentage of said capacity of said fluid receiver body.

A pharmaceutical waste system for treating a residual pharmaceutical composition disposed in a pharmaceutical dispenser includes an extraction stage, a pharmaceutical dispenser coupler, and a pharmaceutical waste treatment stage. The extraction stage is in fluid communication with the pharmaceutical dispenser and is configured to extract at least a portion of the residual pharmaceutical composition from the pharmaceutical dispenser. The pharmaceutical dispenser coupler is configured to couple the pharmaceutical dispenser to the extraction stage. The pharmaceutical waste treatment stage is in fluid communication with the extraction stage and is configured to change the residual pharmaceutical waste composition extracted from the pharmaceutical dispenser in one of a chemical and physical manner. The present disclosure also provides a method of disposing of a residual pharmaceutical composition from a pharmaceutical dispenser.

A pharmaceutical waste disposal assembly () for disposing of raw pharmaceutical waste includes a first receiver body and a second receiver body. The assembly further includes a first reaction agent and a second reaction agent. The first reaction agent and the second reaction agent renders the pharmaceutical waste unrecoverable. The first reaction agent can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent can include activated charcoal.

A pharmaceutical waste disposal assembly () for disposing of raw pharmaceutical waste includes a receiver body () and a first reaction agent (). The receiver body () is configured to receive the pharmaceutical waste. The receiver body () includes a body interior wall (A) that defines a body interior (B). The first reaction agent () is positioned within the body interior (B) so that the first reaction agent () contacts the body interior wall (A) prior to receiving the pharmaceutical waste. The first reaction agent () chemically reacts with the pharmaceutical waste so that the pharmaceutical waste is rendered unrecoverable. The first reaction agent () can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent () can include activated charcoal.

A pharmaceutical waste disposal assembly () for disposing of fluid pharmaceutical waste comprises a fluid receiver body () and a fluid absorber (A). The fluid receiver body () receives the fluid pharmaceutical waste. The fluid absorber (A) is positioned within the fluid receiver body (). The fluid absorber (A) absorbs and retains the fluid pharmaceutical waste. The fluid absorber (A) includes a plurality of levels (L,M,U) that are spaced apart from one another. The plurality of levels (L,M,U) can be oriented substantially vertically relative to one another so that the fluid pharmaceutical waste is distributed to each of the plurality of levels (L,M,U) of the fluid absorber (A).

A pharmaceutical waste disposal assembly () for disposing of raw pharmaceutical waste comprises a first receiver body () and a first reaction agent (). The first receiver body () receives the pharmaceutical waste. The first receiver body () includes a receiver bottom (). The first reaction agent () is positioned within the first receiver body () and spaced apart from the receiver bottom (). The pharmaceutical waste reacts with the first reaction agent () to change the pharmaceutical waste in one of a chemical and physical manner so that the pharmaceutical waste is unrecoverable. The first receiver body () can receive fluid pharmaceutical waste and/or solid pharmaceutical waste. The first reaction agent () may include one or more of a denaturant, an emetic and a tittering agent. For example, the first reaction agent () may include one or more of quinine, ipecac and denatonium benzoate.

A pharmaceutical waste disposal assembly () for disposing of one or more of fluid pharmaceutical waste and solid pharmaceutical waste includes a first waste receiver () and a receiver retainer (). The first waste receiver () includes a first receiver body () having a first body access (BA). Additionally, the pharmaceutical waste moves in a first direction (C) toward the first body access (BA) through which the pharmaceutical waste is directly received by the first receiver body (). The receiver retainer () substantially encloses the first waste receiver (). Further, the first waste receiver () is removable from the receiver retainer (). Moreover, one of the first waste receiver () and the receiver retainer () includes a first waste guide (A) that guides the pharmaceutical waste in a second direction (A) away from the first body access (BA) and in the first direction (C) toward the first body access (BA). Additionally, the first waste guide (A) inhibits removal of the pharmaceutical waste from the first receiver body ().

Pharmaceutical waste disposal assembly including waste diverter

A cancellation feature () for a pharmaceutical waste disposal assembly () having a first surface () and a second surface () can include a first cancellation member () that is secured to the first surface () and a second cancellation member () that is secured to the second surface (). The second cancellation member () automatically moves from a pre-engaged configuration that allows engagement with the first cancellation member () to a post-engaged configuration that inhibits engagement with the first cancellation member (). The automatic movement occurs after engagement and/or during disengagement between the second cancellation member () and the first cancellation member (). The first surface () can form a portion of a receiver that receives pharmaceutical waste, and the second surface () can form a portion of a receiver retainer that retains the receiver. Conversely, the second surface () can form a portion of the receiver and the first surface () can form a portion of the receiver retainer.

Growing community of inventors

Mt. Pleasant, SC, United States of America

David A Maness